Literature DB >> 33377609

Experiences of telemedicine in neurological out-patient clinics during the COVID-19 pandemic.

Espen Saxhaug Kristoffersen1,2, Else Charlotte Sandset3,4, Bendik Slagsvold Winsvold3,5, Kashif Waqar Faiz1, Anette Margrethe Storstein6.   

Abstract

OBJECTIVE: The COVID-19 pandemic has led to rapid changes in the delivery of medical care worldwide. The main objective of this survey was to investigate the initial experiences of neurologists with the use of telemedicine for different neurological conditions during the first phase of the COVID-19.
METHODS: All hospital-based neurologists in Norway (n = 400) were invited to a questionnaire survey by e-mail in April 2020. The study focused on telemedicine and all questions were answered with regard to the first weeks of the pandemic lockdown in Norway.
RESULTS: One-hundred and thirty-five neurologists responded. Overall, 87% reported a shift toward more telemedicine, with significantly more use of telephone than video consultations for both new referrals (54% vs. 30%, P < 0.001) and follow-ups (99% vs. 50%, P < 0.001). Respondents deemed it much more professionally satisfactory to conduct follow-up consultations by telephone, than to carry out consultations with new patients by telephone (85% vs. 13%, P < 0.001). Teleconsultations were better suited for headache and epilepsy patients as compared to multiple sclerosis and movement disorder patients. There was no significant difference between residents and senior consultants regarding how they experienced teleconsultations. Female neurologists found telemedicine better and more effective than male neurologists.
INTERPRETATION: Telemedicine was rapidly implemented in Norwegian neurological departments during the first weeks of the COVID-19 pandemic. Teleconsultations were better suited for follow-ups than for new referrals, and better for headache and epilepsy patients as compared to multiple sclerosis and movement disorder patients.
© 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Entities:  

Year:  2020        PMID: 33377609     DOI: 10.1002/acn3.51293

Source DB:  PubMed          Journal:  Ann Clin Transl Neurol        ISSN: 2328-9503            Impact factor:   4.511


  16 in total

1.  Disparities in Telehealth Care in Multiple Sclerosis.

Authors:  Ruth Ann Marrie; Leanne Kosowan; Gary Cutter; Robert Fox; Amber Salter
Journal:  Neurol Clin Pract       Date:  2022-06

2.  Potential clinical and economic benefits of remote deep brain stimulation programming.

Authors:  Dávid Pintér; Evelyn Járdaházi; József Janszky; Norbert Kovács
Journal:  Sci Rep       Date:  2022-10-19       Impact factor: 4.996

3.  Experiences, distress and burden among neurologists in Norway during the COVID-19 pandemic.

Authors:  Espen Saxhaug Kristoffersen; Bendik Slagsvold Winsvold; Else Charlotte Sandset; Anette Margrethe Storstein; Kashif Waqar Faiz
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

Review 4.  Telemedicine in Pediatric Headache: A Review and Practical Implementation.

Authors:  Scott Rosenthal; Marcy Yonker
Journal:  Curr Neurol Neurosci Rep       Date:  2021-04-12       Impact factor: 5.081

Review 5.  Multiple sclerosis and COVID-19: The Swedish experience.

Authors:  Anne-Marie Landtblom; Shala G Berntsson; Inger Boström; Ellen Iacobaeus
Journal:  Acta Neurol Scand       Date:  2021-05-24       Impact factor: 3.915

6.  One-Year Remission Rate of Chronic Headache Comparing Video and Face-to-Face Consultations by Neurologist: Randomized Controlled Trial.

Authors:  Svein Ivar Bekkelund; Kai Ivar Müller
Journal:  J Med Internet Res       Date:  2021-12-13       Impact factor: 5.428

7.  Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre.

Authors:  Xavier Montalban; Jaume Sastre-Garriga; Alvaro Cobo-Calvo; Ana Zabalza; Jordi Río; Georgina Arrambide; Susana Otero-Romero; Paula Tagliani; Simón Cárdenas-Robledo; Mireia Castillo; Carmen Espejo; Marta Rodriguez; Pere Carbonell; Breogán Rodríguez; Luciana Midaglia; Ángela Vidal-Jordana; Carmen Tur; Ingrid Galan; Joaquín Castillo; Manuel Comabella; Carlos Nos; Cristina Auger; Mar Tintoré; Àlex Rovira
Journal:  J Neurol       Date:  2022-01-10       Impact factor: 6.682

8.  Lessons learned from people with neurological diseases at the time of COVID-19: The EFNA-EAN survey.

Authors:  Benedetta Bodini; Elena Moro; Joke Jaarsma; Elizabeth Cunningham; Johann Sellner; Donna Walsh
Journal:  Eur J Neurol       Date:  2021-10-05       Impact factor: 6.089

Review 9.  Telemedicine application to headache: a critical review.

Authors:  Emanuele Spina; Gioacchino Tedeschi; Antonio Russo; Francesca Trojsi; Rosa Iodice; Stefano Tozza; Aniello Iovino; Francesco Iodice; Gianmarco Abbadessa; Francesco di Lorenzo; Giuseppina Miele; Elisabetta Maida; Giovanni Cerullo; Maddalena Sparaco; Marcello Silvestro; Letizia Leocani; Simona Bonavita; Fiore Manganelli; Luigi Lavorgna
Journal:  Neurol Sci       Date:  2022-01-24       Impact factor: 3.830

10.  Patient's point of view on the use of telemedicine in multiple sclerosis: a web-based survey.

Authors:  Doriana Landi; Marta Ponzano; Carolina Gabri Nicoletti; Gaia Cola; Gianluca Cecchi; Alfonso Grimaldi; Giorgia Mataluni; Nicola Biagio Mercuri; Maria Pia Sormani; Guglielmo Pacileo; Girolama Alessandra Marfia
Journal:  Neurol Sci       Date:  2021-07-20       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.